Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -675 | -272 | -65 | -19 | -7 |
| Depreciation Amortization | 35 | 17 | N/A | N/A | N/A |
| Other Working Capital | -249 | -106 | 7 | 1 | 0 |
| Other Operating Activity | 5 | 2 | 2 | 2 | 1 |
| Operating Cash Flow | $-884 | $-358 | $-56 | $-16 | $-6 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -45 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -25 | -25 |
| Investing Cash Flow | $-45 | $N/A | $N/A | $-25 | $-25 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 894 | 434 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 127 | 127 | 127 |
| Financing Cash Flow | $894 | $434 | $127 | $127 | $127 |
| Beginning Cash Position | 89 | 89 | 26 | 26 | 26 |
| End Cash Position | 55 | 166 | 97 | 112 | 122 |
| Net Cash Flow | $-34 | $77 | $71 | $86 | $96 |
| Free Cash Flow | |||||
| Operating Cash Flow | -884 | -358 | -56 | -16 | -6 |
| Capital Expenditure | -45 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -928 | -358 | -56 | -16 | -6 |